English
Русский
简体中文
Português (Brasil)
Kazakh
Eco-vector
Pharmateca
ISSN 2073-4034 (Print) ISSN 2414-9128 (Online)
Menu     Archives
  • Home
  • About the Journal
    • Editorial Policies
    • Author Guidelines
    • About the Journal
  • Issues
    • Search
    • Current
    • Retracted articles
    • Archives
  • Contact
  • Subscriptions
  • Editorial Board
  • All Journals
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke treatment type 2 diabetes mellitus vitamin D
×
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke treatment type 2 diabetes mellitus vitamin D
Home > Search > Author Details

Author Details

Емельянов, А. С.

Issue Section Title File
Vol 30, No 6/7 (2023) Original articles Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0)
Vol 30, No 6/7 (2023) Original articles Analysis of the effectiveness of various neoadjuvant chemotherapy regimens in patients with T1-3N1-3M0 I–IIIC stage locally advanced breast cancer
Vol 30, No 14 (2023) Oncology The role of cyclin-dependent kinase inhibitors in adjuvant therapy of breast cancer
Vol 32, No 3 (2025) Reviews Prognostic value of low HER2 expression in patients with early breast cancer
 

 

Developed by ECO-VECTOR

 

Powered by EVESYST

TOP